FELICIONI, LARA BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 1.796
AS - Asia 1.115
EU - Europa 1.018
SA - Sud America 131
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 25
OC - Oceania 5
Totale 4.163
Nazione #
US - Stati Uniti d'America 1.731
SG - Singapore 438
CN - Cina 290
GB - Regno Unito 159
IT - Italia 138
UA - Ucraina 137
IE - Irlanda 120
RU - Federazione Russa 106
SE - Svezia 106
BR - Brasile 104
VN - Vietnam 103
FR - Francia 92
TR - Turchia 82
DE - Germania 71
IN - India 62
CA - Canada 41
FI - Finlandia 32
HK - Hong Kong 27
BD - Bangladesh 23
TW - Taiwan 19
PL - Polonia 17
JP - Giappone 12
MX - Messico 11
IQ - Iraq 10
AR - Argentina 9
KR - Corea 9
ES - Italia 7
MY - Malesia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
ID - Indonesia 6
VE - Venezuela 6
IR - Iran 5
PK - Pakistan 5
SC - Seychelles 5
EC - Ecuador 4
ZA - Sudafrica 4
AU - Australia 3
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
SA - Arabia Saudita 3
UG - Uganda 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
NI - Nicaragua 2
NL - Olanda 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
LI - Liechtenstein 1
MN - Mongolia 1
MT - Malta 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
SN - Senegal 1
TH - Thailandia 1
Totale 4.092
Città #
Singapore 343
San Jose 209
Chandler 204
Jacksonville 153
Dublin 117
Beijing 101
Ashburn 99
Southend 70
Council Bluffs 58
Princeton 58
Izmir 52
Dallas 48
Nanjing 47
Los Angeles 44
Santa Clara 37
Altamura 30
Ho Chi Minh City 27
Ann Arbor 26
Cambridge 25
The Dalles 25
Wilmington 23
New York 22
North Bergen 22
Tongling 22
Boardman 21
Hong Kong 21
Hanoi 20
Buffalo 19
Munich 19
Dearborn 14
Nanchang 14
Taichung 14
Atlanta 13
Denver 13
Warsaw 13
Moscow 12
Orem 12
Chennai 11
Montreal 10
Brooklyn 9
Kimball 9
Milan 9
Redondo Beach 9
Rome 9
Tianjin 9
Kunming 8
London 8
Seoul 8
Tokyo 8
Augusta 7
Hebei 7
Washington 7
Woodbridge 7
Brussels 6
Chicago 6
Collecorvino 6
Da Nang 6
Frankfurt am Main 6
Houston 6
Phoenix 6
São Paulo 6
Toronto 6
Cleveland 5
Columbus 5
Grevenbroich 5
Guangzhou 5
Jinan 5
Mexico City 5
Pescara 5
Queens 5
Turku 5
Verona 5
Baghdad 4
Boston 4
Brno 4
Campinas 4
Charlotte 4
Erbil 4
Haiphong 4
Hangzhou 4
Helsinki 4
Jiaxing 4
Kansas City 4
Kuala Lumpur 4
Mumbai 4
New Delhi 4
Ninh Bình 4
Poplar 4
Shenyang 4
Stockholm 4
Sydney 4
Belo Horizonte 3
Bengaluru 3
Biên Hòa 3
Buenos Aires 3
Bến Tre 3
Cassina de' Pecchi 3
Claxton 3
Dong Ket 3
Falls Church 3
Totale 2.409
Nome #
Assessing EGFR mutations. 273
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 222
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays 199
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. 166
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 161
AKT1(E17K) in human solid tumours 161
Mutational profile of GNAQQ209 in human tumors. 160
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. 151
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma. 148
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. 143
Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer 142
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice 141
Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor 140
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications. 138
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation 136
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. 136
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. 131
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. 130
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. 129
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. 128
Correspondence - In Reply - Limitations of Single-Strand Conformation Polymorphism Analysis As a High-Throughput Method for the Detection of EGFR Mutations in the Clinical Setting 127
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. 127
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. 125
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. 125
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. 123
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones. 122
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer. 112
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor 87
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: A study of the Italian NGS Network 80
Totale 4.163
Categoria #
all - tutte 15.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022127 0 0 0 0 8 12 4 18 15 14 16 40
2022/2023511 37 81 29 67 55 94 20 31 73 3 11 10
2023/2024212 19 4 17 7 17 47 45 6 1 16 2 31
2024/2025630 32 107 100 25 16 34 15 22 54 35 84 106
2025/20261.282 85 77 95 155 147 111 195 86 118 97 82 34
2026/2027404 20 54 72 173 85 0 0 0 0 0 0 0
Totale 4.163